According to Vision Research Reports, the North America life science tools market size is projected to reach US$ 80.2 billion by 2027 with registering a CAGR of 11.6% from 2020 to 2027.
The market growth is attributed to a rise in government funding for life science technologies, growth of cell & gene therapies, increasing demand for biopharmaceuticals, and a rise in competition among prominent market entities. Competitive dynamics continue to drive a rapid pace of innovation in sequencing, multiplex platforms, and major categories of mass spectrometry and liquid chromatography; this supports growth via upgrade/replacement cycles and expands the applicability of technologies. An increase in investments for R&D of life science tools is expected to drive the market significantly.
Report Highlights
Cell biology technology dominated the market in 2019 owing to critical attention from key market players and academic institutions
Continuous advancements in technologies required for analysis of cells, such as cytometry, high content analysis, and microscopy, have a great impact on the growth of cancer research, stem cell research, drug discovery, and immunology
Moreover, these advancements have brought about high-throughput, label-free, multiplexing capabilities to cellular analysis
Proteomics technology is anticipated to grow at the fastest CAGR from 2020 to 2027 as proteome analysis provides a complete interpretation of structural and functional information of a cell
This, in turn, helps in the analysis of a cell’s response mechanism against a variety of foreign factors, including drugs
PCR & qPCR is estimated to register the fastest growth rate from 2020 to 2027 owing to the upsurge in PCR adoption for Covid-19 diagnosis
The comprehensive portfolio of cell culture media, advanced surfaces, and vessels displayed by operational entities is a result of an increase in demand for cell culture consumables among research professionals operating in the life science industry
The rise in the adoption of genomic and proteomic workflows in hospitals to diagnose and treat several clinical abnormalities is attributed to the largest share of the healthcare end-use segment in 2019
The U.S. market is expected to grow at a lucrative rate owing to an increase in the adoption of genomic medicines, biopharmaceuticals, and novel technologies for the diagnosis and treatment of clinical disorders
Thermo Fisher Scientific is one of the largest suppliers of a wide range of innovative solutions for the life science community
List of Key Players of North America Life Science Tools Market
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Agilent Technologies
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
Danaher Corporation
General Electric Company
Merck KGaA
QIAGEN
Corning, Inc.
Perkin Elmer, Inc.
Miltenyi Biotec
Bruker
Hitachi Koki Co., Ltd.
Shimadzu Corporation
Oxford Instruments
Genomic Technology
Proteomics Technology
Cell Biology Technology
Other Analytical & Sample Preparation Technology
Lab Supplies & Technologies
Product Outlook
Next-Generation Sequencing
Instrument
Consumables
Services
PCR & qPCR
Instrument
Consumables
Services
Flow Cytometry
Instrument
Consumables
Services
Nuclear Magnetic Resonance Spectroscopy (NMR)
Instrument
Consumables
Services
Microscopy & Electron Microscopy
Instrument
Consumables
Services
Liquid Chromatography (LC)
Instrument
Consumables
Services
Mass Spectrometry (MS)
Instrument
Consumables
Services
Nucleic Acid Preparation (NAP)
Instrument
Consumables
Services
Transfection Electroporation
Equipment
Reagents
Cell Biology
Instrument
Glassware
Culture ware
Others
Consumables
Media & Sera
Reagents
Cell & Tissue Culture Services
Cloning
Kits, Reagents, and Consumables
Services
Other Products & Services
Antibodies
General Supplies
Nucleic Acid Microarray
Instrument
Consumables
Services
Others
Instrument
Consumables
Services
End-use Outlook
Government & Academic
Biopharmaceutical Company
Healthcare
Industrial Application
Others
Country Outlook
U.S.
Canada